A multicenter, randomized, double-blind, parallel controlled clinical trial of spleen Aminopeptide Oral Solution Combined with hyperthermia in the treatment of plantar warts and condyloma acuminatum

Efficacy and safety of spleen Aminopeptide Oral Solution Combined with hyperthermia in the treatment of plantar warts and condyloma acuminatum

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200056764

Enrollment

Unknown

Registered

2022-02-15

Start date

2022-02-15

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar wart, condyloma acuminatum

Interventions

Control group:Spleen Aminopeptide Oral Solution placebo + hyperthermia treatment

Test group:Spleen Aminopeptide Oral Solution + hyperthermia treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Voluntary test and signing informed consent; (2) 18-65 years old, male or female; (3) The clinical diagnosis was plantar wart or condyloma acuminatum.

Exclusion criteria

Exclusion criteria: (1) Pregnant women; (2) Patients treated locally or systematically within 3 months; (3) Patients with skin lesions complicated with other infections; (4) Patients with systemic tumor; (5) Failure to comply with the study protocol, or other circumstances that the investigator considers unsuitable for inclusion; (6) Patients allergic to the study drug.

Design outcomes

Primary

Measure	Time frame
The clearance rate of non target warts at 6 months after treatment; Recovery duration;	—

Secondary

Measure	Time frame
Clinical clearance rate of target lesions at 6 months from treatment;To evaluate the effect of different HPV typing on treatment response;	—

Countries

China

Contacts

Public ContactGao XingHua

The First Affiliated Hospital of China Medical University

gaobarry@hotmail.com13940152467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026